Vitamin K2 (MenaQ7®)

The Bone & Heart Health Vitamin

A patented, clinically validated form of vitamin K2 (menaquinone-7) that contributes to the regulation of calcium by promoting its incorporation into bones and reducing deposition in the arteries.

What is MenaQ7® Good For?

MenaQ7® activates vitamin K-dependent proteins that regulate calcium utilisation. By ensuring calcium is deposited in bones rather than arteries, it promotes bone structure formation and cardiovascular health.

 

MenaQ7® supplementation may lead to:

  • Increased bone mineral density and strength

  • Reduced arterial stiffness that might decrease the risk of cardiovascular conditions

  • Reduced risk of arterial calcification

  • Improved vitamin K status 

What is Vitamin K2 (MenaQ7®)?

Vitamin K2 is part of the vitamin K family but functions very differently from K1. While vitamin K1 functions as a cofactor for blood clotting, Vitamin K2 (particularly MK-7) is involved in activation of osteocalcin and matrix Gla protein (MGP), both critical regulators of calcium metabolism and distribution.

What is the Recommended Daily Dose of MenaQ7®?

Clinical studies support 75µg per day of MenaQ7® as effective for bone and cardiovascular benefits. This aligns with widely used supplemental doses across the EU and global markets.

Things to Know

Source

Natural fermentation of chickpeas or natto (Bacillus subtilis variety natto)

Technology

Patented production process ensuring stability and bioavailability

Region

Manufactured by NattoPharma (now part of Gnosis by Lesaffre)

Data

Backed by >19 published clinical studies in bone and cardiovascular health

MenaQ7® in Detail

Clinical Dose
Clinical Dose

75 µg

Source
Source

Vitamin K2 (menaquinone-7) via fermentation

Technology
Technology

Patented, stabilised MK-7 form with proven bioavailability and shelf-life

Key Benefits
Key Benefits
  • Directs calcium into bones strengthening its structure
  • Reduces arterial calcification, promoting heart health
  • Synergises with vitamin D3 for stronger bones and cardiovascular health
  • Backed by extensive human clinical data
  • Longer half-life than other K2 forms (stays in circulation for up to 72 hours)
Data
Data

Over a decade of peer-reviewed studies on bone density, arterial stiffness, and cardiovascular outcomes

Your Questions About MenaQ7®

Reach us arrow_forward
It’s the patented, clinically proven form of vitamin K2 (MK-7), designed to improve bone and heart health.
It strengthens bones, protects arteries, and works with vitamin D3 for calcium regulation.
Vitamin K1 is used mainly for clotting, while MenaQ7® (K2) regulates calcium metabolism for skeletal and cardiovascular benefits.
Vitamin K2 is safe at recommended doses. Those on anticoagulant therapy should consult their doctor before supplementing.
Yes, it is often paired with vitamin D3, calcium, and magnesium in bone health formulations.

Discover your formula of ingredients

No two people are the same. That’s why your formula is uniquely yours. We select the most effective ingredients based on your health data, lifestyle, and goals — ensuring your capsules are both efficient and safe.

Discover your formulaarrow_forwardMembership planarrow_forward

References

The Science That Supports Us

Cognitive and Neurological Support

Dalmeijer, G.W. et al. (2012) ‘The effect of menaquinone-7 supplementation on circulating species of Matrix Gla Protein’, Atherosclerosis, 225(2), pp. 397–402. doi:10.1016/j.atherosclerosis.2012.09.019. 

Mental Health

Knapen, M.H. et al. (2015) ‘Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women’, Thrombosis and Haemostasis, 113(05), pp. 1135–1144. doi:10.1160/th14-08-0675. 

Nerve Repair

Knapen, M.H., Braam, L.A., Teunissen, K.J., et al. (2015) ‘Yogurt drink fortified with menaquinone-7 improves vitamin K status in a healthy population’, Journal of Nutritional Science, 4. doi:10.1017/jns.2015.25. 

Immune System Support

Nguyen NH and Nguyen AN (2025) Improvement of Bone Mineral Density with Menaq7 360 Mcg: a Case Report. J Nutr Fast Health. 13(4):216-220. DOI: 10.22038/JNFH.2025.86085.1560